These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17062391)

  • 1. Molecular design and delivery of siRNA.
    Inoue A; Sawata SY; Taira K
    J Drug Target; 2006; 14(7):448-55. PubMed ID: 17062391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery systems of small interfering RNA by systemic administration.
    Kawakami S; Hashida M
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic siRNA: principles, challenges, and strategies.
    Gavrilov K; Saltzman WM
    Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Know-how of RNA interference and its applications in research and therapy.
    Wadhwa R; Kaul SC; Miyagishi M; Taira K
    Mutat Res; 2004 Sep; 567(1):71-84. PubMed ID: 15341903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene silencing by small interfering RNA-based knock-down technology.
    Zhang J; Hua ZC
    Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference: from gene silencing to gene-specific therapeutics.
    Leung RK; Whittaker PA
    Pharmacol Ther; 2005 Aug; 107(2):222-39. PubMed ID: 15908010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing of HIV-1 by RNA interference.
    Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):57-65. PubMed ID: 15185724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
    Wullner U; Neef I; Tur MK; Barth S
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference and the use of small interfering RNA to study gene function in mammalian systems.
    Bantounas I; Phylactou LA; Uney JB
    J Mol Endocrinol; 2004 Dec; 33(3):545-57. PubMed ID: 15591019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial delivery of siRNAs: a new approach to solid tumor therapy.
    Xu DQ; Zhang L; Kopecko DJ; Gao L; Shao Y; Guo B; Zhao L
    Methods Mol Biol; 2009; 487():161-87. PubMed ID: 19301647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference: the molecular immune system.
    Bagasra O; Prilliman KR
    J Mol Histol; 2004 Aug; 35(6):545-53. PubMed ID: 15614608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.